Financhill
Back

ADMA Biologics Quote, Financials, Valuation and Earnings

ADMA Biologics Price Quote

$6.54
+0.34 (+5.48%)
(Updated: April 23, 2024 at 6:55 PM ET)

ADMA Biologics Key Stats

Buy
75
ADMA Biologics (ADMA) is a Buy

Day range:
$6.19 - $6.48
52-week range:
$3.06 - $6.76
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.38
P/B ratio:
10.47%

Volume:
2M
Avg. volume:
2.5M
1-year change:
73.18%
Market cap:
$1.4B
Revenue:
$258.2M
EPS:
$-0.13

How Much Does ADMA Biologics Make?

Is ADMA Biologics Growing As A Company?

  • What Is ADMA Biologics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.48%
  • What Is ADMA Biologics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ADMA Biologics Stock Price Performance

  • Did ADMA Biologics Stock Go Up Last Month?
    ADMA Biologics share price went down by -1.43% last month
  • Did ADMA's Share Price Rise Over The Last Year?
    ADMA share price rose by 73.18% over the past 1 year

What Is ADMA Biologics 52-Week High & Low?

ADMA Biologics Price To Free Cash Flow

Is It Risky To Buy ADMA Biologics?

  • How Much Debt Does ADMA Biologics Have?
    Total long term debt quarterly is $130.6M
  • How Much Cash Does ADMA Biologics Have?
    Cash and short term investments quarterly total is $51.4M
  • What Is ADMA Biologics’s Book Value Per Share?
    Book value per share is 0.60

Is ADMA Biologics Cash Flow Positive?

  • What Is ADMA Cash Flow From Operations?
    Cash flow from operations (TTM) is $8.8M
  • What Is ADMA Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$39M
  • What Is ADMA Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$5M

ADMA Biologics Return On Invested Capital

  • Is Management Doing A Good Job?
    ADMA return on invested capital is -9.87%
  • What Is ADMA Biologics Return On Assets?
    ROA measures how assets are converting to revenues and is -8.26%
  • What Is ADMA Return On Equity?
    ROE is a measure of profitability and is -19.31%

ADMA Biologics Earnings Date & Stock Price

ADMA Biologics Competitors

  • Who Are ADMA Biologics's Competitors?
    Below is a list of companies who compete with ADMA Biologics or are related in some way:
    • ANI Pharmaceuticals Inc (ANIP)
    • Bristol-Myers Squibb Co (BMY)
    • Ligand Pharmaceuticals Inc (LGND)
    • Puma Biotechnology Inc (PBYI)
    • Vanda Pharmaceuticals Inc (VNDA)

ADMA Biologics Dividend Yield

Data Unavailable

ADMA Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 153.33%
Revenue: 47.86% 1.29%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.38
Upside from Last Price: 35.08%

Major Shareholders

  • How many ADMA shares are owned by institutional investors?
    259.4M ADMA shares are owned by institutional investors
  • How many ADMA shares are owned by insiders?
    4.7M ADMA shares are owned by insiders